Get the Stockscreener App
12.93
2.49%
-0.33
After Hours:
13.27
0.34
+2.63%
Evolent Health Inc stock is traded at $12.93, with a volume of 2.26M.
It is down -2.49% in the last 24 hours and down -46.17% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$13.26
Open:
$13.14
24h Volume:
2.26M
Relative Volume:
1.02
Market Cap:
$1.49B
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-12.68
EPS:
-1.02
Net Cash Flow:
$150.93M
1W Performance:
+14.32%
1M Performance:
-46.17%
6M Performance:
-44.46%
1Y Performance:
-56.26%
1-Day Range:
$12.83
$13.62
1-Week Range:
$11.17
$13.62
52-Week Range:
$11.17
$35.00
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
800 NORTH GLEBE RD, SUITE 500, ARLINGTON
Compare EVH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
12.93 | 1.49B | 2.35B | -74.42M | 150.93M | -1.02 |
|
VEEV
Veeva Systems Inc
|
226.76 | 36.93B | 2.57B | 615.26M | 996.76M | 3.32 |
|
SOLV
Solventum Corp
|
72.48 | 12.43B | 8.26B | 66.00M | 1.17B | 0.00 |
|
TEM
Tempus Ai Inc
|
62.98 | 10.01B | 640.44M | -743.28M | -206.93M | 0.00 |
|
DOCS
Doximity Inc
|
53.39 | 9.94B | 493.63M | 160.55M | 162.20M | 0.55 |
|
HQY
Healthequity Inc
|
102.47 | 8.91B | 1.10B | 105.67M | -197.98M | 0.1475 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent Health, Inc. (NYSE:EVH) Shares Sold by Eagle Asset Management Inc. - MarketBeat
JPMorgan Chase & Co. Has Lowered Expectations for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Foundry Partners LLC Buys New Position in Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Stephens & Co. Downgrades Evolent Health (EVH) - MSN
Evolent Health Inc (EVH) Stock Price Down 4.77% on Nov 20 - GuruFocus.com
10 Best Small-Cap Stocks Ready To Explode - Insider Monkey
Evolent Health, Inc. (EVH): This Small-Cap Stock Is Ready To Explode - Insider Monkey
State of New Jersey Common Pension Fund D Makes New Investment in Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Evolent Health (NYSE:EVH) Price Target Lowered to $28.00 at Oppenheimer - MarketBeat
250,000 Shares in Evolent Health, Inc. (NYSE:EVH) Bought by Royce & Associates LP - MarketBeat
Evolent Health, Inc. to Release Fourth Quarter and Full Year 2021 Operating Results and Host Conference Call on Wednesday, February 23, 2022 - Quantisnow
Humana and Evolent expand partnership to enhance oncology care - The Cancer Letter
Evolent Health stock hits 52-week low at $12.28 - Investing.com
Evolent Health stock hits 52-week low at $12.28 By Investing.com - Investing.com Canada
EVH (Evolent Health) Other Current Assets : $40 Mil (As of Sep. 2024) - GuruFocus.com
Evolent Health's SWOT analysis: stock faces headwinds amid growth potential By Investing.com - Investing.com Nigeria
Evolent Health's SWOT analysis: stock faces headwinds amid growth potential - Investing.com
Evolent Health Inc (EVH) Trading Down 7.65% on Nov 13 - GuruFocus.com
FMR LLC Adjusts Stake in Evolent Health Inc - GuruFocus.com
Evolent Health Inc (EVH) Shares Down 4.96% on Nov 12 - GuruFocus.com
Royal Bank of Canada Reiterates Outperform Rating for Evolent Health (NYSE:EVH) - MarketBeat
Evolent Health: A Shot At Revival After Market Bruising (NYSE:EVH) - Seeking Alpha
Evolent Health (NYSE:EVH) Sees Strong Trading VolumeStill a Buy? - MarketBeat
Barclays Has Lowered Expectations for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Evolent Health, Inc. (NYSE:EVH) Q3 2024 Earnings Call Transcript - Insider Monkey
Take Care Before Jumping Onto Evolent Health, Inc. (NYSE:EVH) Even Though It's 49% Cheaper - Simply Wall St
Evolent Health Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Compared to Estimates, Evolent Health (EVH) Q3 Earnings: A Look at Key Metrics - MSN
Evolent Health downgraded at Stephens amid surging cancer costs - Yahoo Finance
Evolent Health price target lowered to $20 from $42 at RBC Capital - TipRanks
Evolent Health price target lowered to $36 from $45 at BTIG - TipRanks
Evolent Health stock hits 52-week low at $14.69 amid market shifts - Investing.com India
Evolent Health Inc Class A (EVH) Quarterly 10-Q Report - Quartzy
RSI Alert: Evolent Health (EVH) Now Oversold - Nasdaq
Oppenheimer Has Lowered Expectations for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Evolent Health price target lowered to $27 from $43 at JMP Securities - TipRanks
Hollencrest Capital Management Sells 66,825 Shares of Evolent Health, Inc. (NYSE:EVH) - MarketBeat
Evolent Health (NYSE:EVH) Reaches New 52-Week LowHere's Why - MarketBeat
Evolent Health falls on annual revenue, adjusted profit forecast cut - XM
Cracking The Code: Understanding Analyst Reviews For Evolent Health - Benzinga
Sweetgreen Posts Downbeat Results, Joins Evolent Health, Redfin, Pinterest And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Evolent Health (NYSE:EVH) Lowered to Equal Weight Rating by Stephens - MarketBeat
Evolent Health Explores Sale, Garners Inbound Interest From Private Equity Firms - MSN
Evolent Health Shares Plunge on 3Q Results Miss, Full-Year Outlook Cut - MarketWatch
Evolent Health (EVH) Q3 Earnings and Revenues Lag Estimates - MSN
Evolent Health Inc (EVH) Q3 2024 Earnings Call Highlights: Navig - GuruFocus.com
Evolent Health Inc (EVH) Q3 2024 Earnings Call Highlights: Navigating Medical Cost Challenges ... By GuruFocus - Investing.com Canada
Evolent Health Inc (EVH) Q3 2024 Earnings Call Highlights: Navigating Medical Cost Challenges ... - Yahoo Finance
Evolent Health (EVH) Q3 2024 Earnings Call Transcript - AOL
Why Evolent Health (EVH) is Poised to Beat Earnings Estimates Again - MSN
Evolent Health Reports Revenue Growth Amid Challenges - TipRanks
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):